Clinical Trial

Study of the Role of Top-down Processes in Neuronal Reorganization and Recovery From Sensory Loss: an Exploratory Behavioral and Electroencephalographic Study in Cochlear-supported Deaf Patients

Study acronym: REASCENT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study posits that central top-down processes (attention, inhibition), marked by alpha oscillations in EEG, play a key role. Understanding the evolution of these neuronal signatures and their link to pre-implantation visual dependence could allow the identification of biomarkers predictive of the success of auditory rehabilitation.
Trial Details
NCT Number NCT07500909
Lead Sponsor University Hospital, Toulouse
Collaborators: Centre de recherche Cerveau et Cognition (CERCO)
Conditions Deafness, Bilateral
Enrollment 90 participants
Start Date 2026-03-01
Primary Completion 2029-03-01 (estimated)
Study Completion 2029-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-30